Crossref
Resistance to BTK inhibitors in chronic lymphocytic leukaemia – from the C481S mutation to non-genetic mechanisms of tumour adaptation
Transfuze a hematologie dnes · 15.06.2026 · 32 (2)
DOI: 10.48095/cctahd202615 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfuze a hematologie dnes, online erschienen am 15.06.2026. Verfasst von Martin Šimkovič und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Šimkovič, M., & Écsiová, D. (2026). Resistance to BTK inhibitors in chronic lymphocytic leukaemia – from the C481S mutation to non-genetic mechanisms of tumour adaptation. Transfuze a hematologie dnes, 32(2). https://doi.org/10.48095/cctahd202615
Vancouver
Šimkovič M, Écsiová D. Resistance to BTK inhibitors in chronic lymphocytic leukaemia – from the C481S mutation to non-genetic mechanisms of tumour adaptation. Transfuze a hematologie dnes. 2026;32(2). doi:10.48095/cctahd202615
BibTeX
@article{imkovi2026,
author = {Šimkovič, Martin and Écsiová, Dominika},
title = {Resistance to BTK inhibitors in chronic lymphocytic leukaemia – from the C481S mutation to non-genetic mechanisms of tumour adaptation},
journal = {Transfuze a hematologie dnes},
year = {2026},
volume = {32},
number = {2},
doi = {10.48095/cctahd202615}
}
EUVIMED